The next frontier in mental health: from research to patients.


WHEN: Tuesday, April 24, 2012

8:30 a.m. – 5:45 p.m.

LOCATION: MaRS Discovery District, 101 College Street, Suite 100, Toronto, ON, M5G 1L7


This symposium is the follow up to a symposium held in Montreal last May with the Gairdner Foundation: “Frontiers in Mental Health”, where distinguished researchers from around the world gathered to advance our understanding of a range of mental illnesses in light of recent discoveries. As the title suggests, the 2012 Symposium will move the discussion further along to treatment, and will look at examples of programs that address first episode and early detection, with a particular focus on schizophrenia and bipolar disorder. There will also be a section on children and youth mental health. This will not just be a series of presentations: the goal of this Symposium is to discuss how best to promote patient-oriented research networks across Canada to accelerate the discovery and adoption of meaningful change in the diagnosis and treatment of individuals living with chronic forms of mental illness.

Jean Addington, Alberta Centennial Mental Health Research Chair & Novartis Chair in Schizophrenia Research; Professor, Department of Psychiatry, University of Calgary, Calgary, AB
Jean-Luc Taschereau, President, Mental Illness Foundation, Montréal, QC, joined by Bianca Petrilli and James Graves, two Partners for Life facilitators
Anne C. Duffy, Professor Senior Clinical Research Scholar Department of Psychiatry Dalhousie University, Halifax, NS
Robert K. Heinssen, Director, Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, M.D., USA
Michael Krausz, UBC Providence Leadership Chair for Addiction Research; Professor of Psychiatry, School of Population and Public Health, University of British Columbia (UBC); UBC Program Director Addiction Psychiatry, Vancouver, BC
Stanley Kutcher, Sun Life Financial Chair in Adolescent Mental Health, Dalhousie University and the IWK Health Center, Halifax, NS
Ashok Malla, Professor, Department of Psychiatry and Adjunct Professor, Department of Epidemiology, McGill University; Director, Prevention and Early intervention Program for Psychoses, Douglas Mental Health University Institute, Montréal, QC
Husseini K. Manji, Global Therapeutic Area Head, Neuroscience Research & Development, Johnson & Johnson Pharmaceuticals Group, NJ, USA
Anthony Phillips, Scientific Director, CIHR Institute of Neurosciences, Mental Health and Addiction; Professor, Department of Psychiatry, University of British Columbia; Senior Scientist, UBC-VCHRI Brain Research Centre, Vancouver, BC
Delbert Robinson, Professor of Psychiatry and of Molecular Medicine, Hofstra North Shore-LIJ School of Medicine, Feinstein Institute for Medical Research, NY, USA
Nina R. Schooler, Professor of Psychiatry and Behavioral Sciences, State University of New York Downstate Medical Center, Brooklyn, NY, USA
Peter Szatmari, Chedoke Health Corporation Chair in Child Psychiatry Professor, Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON
Gustavo Turecki, Professor and Vice-Chair, Research and Academic Affairs, Department of Psychiatry, McGill University; Director, McGill Group for Suicide Studies; Head, Depressive Disorders Program; Douglas Mental Health Institute, Montréal, QC
Robert B. Zipursky, Department of Psychiatry and Behavioural Neurosciences, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON

Please register in advance to attend this event. There is no registration fee. To register, please visit our website at or for more information call 514-904-0551.


Partners include the Canadian Institutes of Health Research-Institute of Neurosciences, Mental Health and Addiction, Douglas Mental Health University Institute, CHU Sainte-Justine, McGill University, Université de Montréal, Brain & Behavior Research Foundation (formerly NARSAD), and Mental Health Commission of Canada.

March 6, 2012